Smith Group Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-58,430	Closed	-$878K	–	188
2025 Q2	$878K	Buy	58,430 +15,430	+36%	+$220K	0.06%	97
2025 Q1	$567K	Sell	43,000 -400	-0.9%	-$5.52K	0.04%	125
2024 Q4	$685K	Buy	+43,400	New	+$652K	0.05%	110
2022 Q1	$629K	Sell	56,450 -500	-0.9%	-$5.67K	0.03%	107
2021 Q4	$745K	Sell	56,950 -1,500	-3%	-$18.9K	0.03%	114
2021 Q3	$761K	Buy	58,450 +6,950	+13%	+$92.6K	0.04%	103
2021 Q2	$757K	Buy	51,500 +3,200	+7%	+$44.8K	0.04%	98
2021 Q1	$593K	Buy	48,300 +3,200	+7%	+$41.1K	0.03%	121
2020 Q4	$643K	Sell	45,100 -4,000	-8%	-$53.9K	0.04%	113
2020 Q3	$683K	Sell	49,100 -11,650	-19%	-$139K	0.04%	115
2020 Q2	$644K	Sell	60,750 -10,650	-15%	-$108K	0.04%	120
2020 Q1	$576K	Buy	+71,400	New	+$595K	0.03%	115
2014 Q2	–	Sell	-28,975	Closed	-$254K	–	444
2014 Q1	$254K	Sell	28,975 -750	-3%	-$6.52K	0.01%	210
2013 Q4	$244K	Hold	29,725	–	–	0.01%	209
2013 Q3	$225K	Hold	29,725	–	–	0.01%	219
2013 Q2	$225K	Buy	+29,725	New	+$217K	0.01%	224